SCHEMBL9729536

SCHEMBL9729536

O=C1CCC(c2cccc(F)c2)(c2cccc(F)c2)C2CN(Cc3ccccc3)CC12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 1/20 0.42
CXCR3 P49682 2/20 0.41
DRD2 P14416 2/20 0.41
DRD3 P35462 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM3 P20309 1/20 0.41
TACR1 P25103 3/20 0.41
TSHR P16473 2/20 0.41
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP2D6 P10635 2/20 0.40
MAPK1 P28482 1/20 0.40
BACE1 P56817 1/20 0.39
SIGMAR1 Q99720 2/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9003055 0.89 TACR1 (0.48) CXCR3TACR1TSHRMEN1CYP3A4
SCHEMBL9268452 0.89 TACR1 (0.48) CXCR3TACR1TSHRMEN1CYP3A4
SCHEMBL9003052 0.89 TACR1 (0.48) CXCR3TACR1TSHRMEN1CYP3A4
SCHEMBL9729382 0.88 DPP4 (0.46) CCR5CXCR3DRD2DRD3CHRM2
SCHEMBL9729281 0.87 MEN1 (0.43) CCR5CXCR3CHRM2CHRM3TACR1
SCHEMBL9730188 0.81 MAPT (0.48) CCR5TACR1TSHRMEN1CYP3A4
SCHEMBL9729134 0.81 TACR1 (0.39) CXCR3DRD2DRD3TACR1TSHR
SCHEMBL8874365 0.79 GAA (0.44) TACR1TSHRMEN1CYP3A4MAPT
SCHEMBL8875025 0.75 GAA (0.46) DRD2DRD3TACR1DPP4
SCHEMBL9730461 0.74 TSHR (0.47) CCR5CHRM2CHRM3TACR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5112988-A ISOINDOLONE DERIVATIVES RHONE-POULENC SANTE (FR) 1992-05-12 US disclosed
US-5102667-A Antiallergens, antiinflammatory agents, nervous system disorders, immunology, psychological disorders RHONE-POULENC SANTE (FR) 1992-04-07 US disclosed